External Advisory Committee
The External Advisory Committee is comprised of leaders in the field of clinical and translational science, CTSA PIs, and experts in minority health and health disparities research. Members meet twice a year, once in person and once via conference call to offer visionary direction, make recommendations about the Institute’s scope, purpose, and progress; and, help integrate Miami CTSI initiatives, policies, and procedures with those of NCATS and NIMHD.
Alex Adjei, M.D., Ph.D, FACP
Mayo Clinic, Rochester, MN
Consultant, Medical Oncology
Director, Early Cancer Therapeutics Program
Director, Global Oncology
Professor of Oncology, Mayo Clinic College of Medicine
Peter Embi, M.D., M.S., FACP, FACMI
President and Chief Executive Officer, Regenstrief Institute Inc.
Patricia Ann Furlong
Founder/President and CEO, Parent Project Muscular Dystrophy
Juan Carlos Lopez, Ph.D.
Founder, Haystack Science
Former Head, Academic Relations & Collaborations, Roche
David R. Nelson, M.D.
University of Florida
Director & PI, Clinical and Translational Science Institute
OneFlorida Clinical Research Consortium Director
Associate Dean, Clinical Research
Professor of Medicine, Molecular Genetics, and Microbiology
Harold A. Pincus, M.D.
Professor and Vice Chair for Strategic Initiatives, Department of Psychiatry
Co-Director, Irving Institute for Clinical and Translational Research
Director of Quality and Outcomes Research, New York-Presbyterian Hospital
Director, Health and Aging Policy Fellows National Program
Senior Scientist, RAND Corporation, Pittsburgh, PA
David S. Stephens, M.D.
Principal Investigator, Atlanta Clinical and Translational Science Institute
Vice President of Research, Robert W. Woodruff Health Sciences Center
Chief of Medicine, Emory Healthcare
Chair of the Department of Medicine in Emory University School of Medicine
Stephen W. Schwarzmann Distinguished Professor of Medicine